1. Metagenomic analysis of RNA sequencing data reveals SARS-CoV-2-mediated progressive dysbiosis of upper respiratory tract microbiota
- Author
-
Ganesan Velmurugan and Dinakaran Vasudevan
- Subjects
Commensal bacteria ,0301 basic medicine ,Medicine (General) ,QH301-705.5 ,viruses ,Respiratory System ,Biology ,medicine.disease_cause ,Virus ,Microbiology ,03 medical and health sciences ,R5-920 ,0302 clinical medicine ,Immunity ,medicine ,Animals ,Humans ,Upper respiratory tract microbiota ,Biology (General) ,skin and connective tissue diseases ,Coronavirus ,Sequence Analysis, RNA ,SARS-CoV-2 ,Microbiota ,fungi ,Ferrets ,COVID-19 ,virus diseases ,RNA ,General Medicine ,medicine.disease ,body regions ,030104 developmental biology ,medicine.anatomical_structure ,Metagenomics ,Infectious disease (medical specialty) ,030220 oncology & carcinogenesis ,Dysbiosis ,Original Article ,Respiratory tract - Abstract
COVID-19, an infectious disease caused by a novel coronavirus (SARS-CoV-2) has emerged as global pandemic. Here, we are describing the changes in microbiota of upper respiratory tract by analyzing the publically available RNA-sequencing data of SARS-CoV-2 infected ferrets. The bacterial dysbiosis due to SARS-CoV-2 is largely inversely proportional to the dysbiosis caused by influenza-A virus. The bacterial taxa, which are defined as healthy ecostate are significantly reduced during SARS-CoV-2 infection. Altogether, this preliminary study provides a new insight on the possible role of bacterial communities of upper respiratory tract in determining the immunity, susceptibility, and mortality for COVID-19.
- Published
- 2021
- Full Text
- View/download PDF